OOIR: Observatory of International Research

Papers

(The TQCC of Blood Cells Molecules and Diseases is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)

Article	Citations
Increased expression of CD8 marker on T-cells in COVID-19 patients	110
Leukocyte adhesion to P-selectin and the inhibitory role of Crizanlizumab in sickle cell disease: A standardized microfluidic assessment	35
Effect of age, comorbidity and remission status on outcome of COVID-19 in patients with hematological malignancies	30
ABO blood groups, COVID-19 infection and mortality	26
Direct and indirect effects of the SARS-CoV-2 pandemic on Gaucher Disease patients in Spain: Time to reconsider home-based therapies?	25
Effectiveness of convalescent plasma in Indian patients with COVID-19	24
Hematologically important mutations: The autosomal forms of chronic granulomatous disease (third update)	23
Down-regulation of lncRNA NEAT1 regulated by miR-194-5p/DNMT3A facilitates acute myeloid leukemia	20
Hematologically important mutations: X-linked chronic granulomatous disease (fourth update)	20
Circ-PTK2 promotes the proliferation and suppressed the apoptosis of acute myeloid leukemia cells through targeting miR-330-5p/FOXM1 axis	18
Is the erythropoietin-erythroferrone-hepcidin axis intact in human neonates?	16
Facing COVID-19 in the hematopoietic cell transplant setting: A new challenge for transplantation physicians	16
A case of VEXAS syndrome associated with EBV-associated hemophagocytic lymphohistiocytosis	15
Potential causal role of l-glutamine in sickle cell disease painful crises: A Mendelian randomization analysis	14
MicroRNA expression patterns in HbE/β-thalassemia patients: The passwords to unlock fetal hemoglobin expression in β-hemoglobinopathies	14
BRAF V600E mutation in childhood Langerhans cell histiocytosis correlates with multisystem disease and poor survival	14
Sickle cell disease clinical phenotypes in Nigeria: A preliminary analysis of the Sickle Pan Africa Research Consortium Nigeria database	13
Acquired von Willebrand syndrome in ECMO patients: A 3-year cohort study	12
Upregulation of cytokine signalling in platelets increases risk of thrombophilia in severe COVID-19 patients	12
EPAS1 regulates proliferation of erythroblasts in chronic mountain sickness	12
The potential role of emicizumab prophylaxis in severe von Willebrand disease	12
Numbers of long-term hematopoietic stem cells from bone marrow of fanca and fancc knockout mice can be greatly enhanced by their collection and processing in physioxia conditions	11
Lysophosphatidic acid-induced pro-thrombotic phosphatidylserine exposure and ionophore-induced microvesiculation is mediated by the scramblase TMEM16F in erythrocytes	11
Hematologically important mutations: Leukocyte adhesion deficiency (second update)	10
Hypoxia induced up-regulation of tissue factor is mediated through extracellular RNA activated Toll-like receptor 3-activated protein 1 signalling	10

Clinical and health-related quality of life outcomes of transfusion-dependent thalassaemia patients in Singapore	9
Comparison of efficacy and safety of thalidomide vs hydroxyurea in patients with Hb E-β thalassemia - a pilot study from a tertiary care Centre of India	9
Daratumumab for pure red cell aplasia post ABO incompatible allogeneic hematopoietic stem cell transplant for aplastic anemia	9
Severe immune thrombocytopenia after COVID-19 vaccination: Report of four cases and review of the literature	9
Thrombin generation in plasma of patients with haemophilia A and B with inhibitors: Effects of bypassing agents and antithrombin reduction	9
Benserazide as a potential novel fetal hemoglobin inducer: an observational study in non-carriers of hemoglobin disorders	9
Mitapivat increases ATP and decreases oxidative stress and erythrocyte mitochondria retention in a SCD mouse model	9
Frequency and perturbations of various peripheral blood cell populations before and after eculizumab treatment in paroxysmal nocturnal hemoglobinuria	9
The IL-33 Receptor/ST2 acts as a positive regulator of functional mouse bone marrow hematopoietic stem and progenitor cells	9
Benserazide racemate and enantiomers induce fetal globin gene expression in vivo: Studies to guide clinical development for beta thalassemia and sickle cell disease	8
Potential ‘significance’ of monoclonal gammopathy of ‘undetermined significance’ during COVID-19 pandemic	8
RNF220 promotes the proliferation of leukaemic cells and reduces the degradation of the Cyclin D1 protein through USP22	8
Effects of Eupalinilide E and UM171, alone and in combination on cytokine stimulated ex-vivo expansion of human cord blood hematopoietic stem cells	8
Prognostic factors associated with COVID-19 related severity in sickle cell disease	8
Early iron supplementation and iron sufficiency at one month of age in NICU patients at-risk for iron deficiency	7
Novel mutations in the bone morphogenetic protein 6 gene in patients with iron overload and non-homozygous genotype for the HFE p.Cys282Tyr mutation	7
High-throughput methods for the analysis of transcription factors and chromatin modifications: Low input, single cell and spatial genomic technologies	7
Performance of serum procalcitonin as a biochemical predictor of death in hematology patients with febrile neutropenia	7
The association of HBG2, BCL11A, and HBS1L-MYB polymorphisms to thalidomide response in Chinese β-thalassemia patients	7
Biomarkers and genetic modulators of cerebral vasculopathy in sub-Saharan ancestry children with sickle cell anemia	7
Age of first pain crisis and associated complications in the CASiRe international sickle cell disease cohort	7
Loss of ZNF215 imprinting is associated with poor five-year survival in patients with cytogenetically abnormal-acute myeloid leukemia	7
A case series highlighting structured hematological, biochemical and molecular approach to clinical oral iron refractoriness in children: A pressing need for a 3-tier system for classification of vari	6
Global geographic differences in healthcare utilization for sickle cell disease pain crises in the CASiRe cohort	6
Targeted gene expression study using TaqMan low density array to gain insights into venous thrombo-embolism (VTE) pathogenesis at high altitude	6
Novel mutations in the EPO-R, VHL and EPAS1 genes in the Congenital Erythrocytosis patients	6
Aberrant expression of cytokines in polycythemia vera correlate with the risk of thrombosis	6
Prognostic significance of CD45 antigen expression in pediatric acute lymphoblastic leukemia	5
Development of a Thalassemia International Prognostic Scoring System (TIPSS)	5
A computational study of structural differences of binding of NADP+ and G6P substrates to G6PD Mediterraneanc.563T, G6PD A−c.202A/c.376G, G6PD Cairoc.404C and G6PD Gazac.536A mutations	5
γ′ fibrinogen levels as a biomarker of COVID-19 respiratory disease severity	5
VCAM1, HMOX1 and NOS3 differential endothelial expression may impact sickle cell anemia vasculopathy	5
Pediatric bone marrow failure: Clinical, hematological and targeted next generation sequencing data	5
Bone marrow burden score is not useful as a follow-up parameter in stable patients with type 1 Gaucher disease after 5 years of treatment	5
No evidence that chloroquine or hydroxychloroquine induce hemolysis in G6PD deficiency	5
The significance of surface neutrophilic MPO expression level in NETosis and NETosis-associated coagulopathies in covid-19 infected patients	5
Splicing analysis of SLC40A1 missense variations and contribution to hemochromatosis type 4 phenotypes	5
The effect of transfusion on immune responses in thalassemia	4
Haemoglobin Bristol-Alesha in a child with non-spherocytic severe haemolytic anaemia and marked anisochromic poikilocytosis with basophilic stippling and amorphous intracellular content	4
ANKHD1 is an S phase protein required for histone synthesis and DNA repair in multiple myeloma cells	4
Modulation of red blood cell oxygen affinity with a novel allosteric modifier of hemoglobin is additive to the Bohr effect	4
Heterogeneous phenotype of Hereditary Xerocytosis in association with PIEZO1 variants	4
Analysis of baseline characteristics, disease burden and long-term follow-up of 167 patients with Paroxysmal Nocturnal Hemoglobinuria at a single center in Brazil	4
Co-morbidities and mortality in patients with sickle cell disease in England: A 10-year cohort analysis using hospital episodes statistics (HES) data	4
Molecular genetic diagnosis by next-generation sequencing in a cohort of Mexican patients with haemophilia and report of novel variants	4
Effects of d-ribose on human erythrocytes: Non-enzymatic glycation of hemoglobin, eryptosis, oxidative stress and energy metabolism	4
Sirolimus for treatment of refractory primary warm autoimmune hemolytic anemia in children	4
JAK2V617F mutant endothelial cells promote neoplastic hematopoiesis in a mixed vascular microenvironment	4
Comparison of CRP and procalcitonin for etiological diagnosis of fever during febrile neutropenia in hematology patients- an experience from a tertiary care center in Northern India	4
Mutations in RASGRP2 gene identified in patients misdiagnosed as Glanzmann thrombasthenia patients	4

A decade of changes in management of immune thrombocytopenia, with special focus on elderly patients	4
Congenital dyserythropoietic anemia type I: First report from the Congenital Dyserythropoietic Anemia Registry of North America (CDAR)	4
Good treatment-free survival of monoclonal gammopathy of undetermined significance associated pure red cell aplasia after bortezomib plus dexamethasone	4
Novel histone deacetylase inhibitor CT-101 induces γ-globin gene expression in sickle erythroid progenitors with targeted epigenetic effects	4
Anti-TFPI for hemostasis induction in patients with rare bleeding disorders, an ex vivo thrombin generation (TG) guided pilot study	4
Differential tissue specific expression of Kif23 alternative transcripts in mice with the human mutation causing congenital dyserythropoietic anemia type III	4
Age-dependent characterization of carotid and cerebral artery geometries in a transgenic mouse model of sickle cell anemia using ultrasound and microcomputed tomography	4
Identification and characterization of novel mutations in Chinese patients with congenital fibrinogen disorders	4
TMEM16F mediated phosphatidylserine exposure and microparticle release on erythrocyte contribute to hypercoagulable state in hyperuricemia	4